MG
ZBH icon

Michael Gelband’s Zimmer Biomet ZBH Stock Holding History

Michael Gelband’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,900
Closed -$3.58M – 2293
2020
Q2 		$3.58M Buy
+30,900
New +$3.56M 0.09% 236

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Michael Gelband's ZBH Position: Q2 2026 in Review

Michael Gelband increased its Zimmer Biomet (ZBH) stake by 87% in Q2 2026, buying an estimated $7.39M and bringing the position to 180,884 shares worth $15.6M. The position accounts for 0.1% of the portfolio, ranked #186.

Michael Gelband first reported a position in ZBH in Q4 2018 and has held it in 22 quarters since. The position peaked at $39M in Q4 2023. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Michael Gelband held 180,884 shares of Zimmer Biomet worth $15.6M as of Q2 2026.
  • Michael Gelband bought 84,284 Zimmer Biomet shares in Q2 2026, an estimated $7.39M.
  • Zimmer Biomet made up 0.1% of Michael Gelband's portfolio in Q2 2026, its #186 holding.
  • Michael Gelband first reported a position in Zimmer Biomet in Q4 2018 and has held it in 22 quarters since.
  • Michael Gelband's Zimmer Biomet position peaked at $39M in Q4 2023.
  • 904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.